We serve Chemical Name:Phenyl-vinylsulfon CAS:5535-48-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Phenyl-vinylsulfon
CAS.NO:5535-48-8
Synonyms:Sulfone, phenyl vinyl;ethenylsulfonylbenzene;Phenyl-vinylsulfon;EINECS 226-890-2;(vinyl sulfonyl) benzene;phenyl vinyl sulfone;Phenylvinylsultone;(Vinylsulfonyl)benzene;Benzene, (ethenylsulfonyl)-;ethenyl phenyl sulfone;MFCD00007554
Molecular Formula:C8H8O2S
Molecular Weight:168.213
HS Code:2930909090
Physical and Chemical Properties:
Melting point:67-69 °C(lit.)
Boiling point:314.4±15.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.537
PSA:42.52000
Exact Mass:168.024506
LogP:1.20
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Sulfone, phenyl vinyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00007554 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenylvinylsultone Use and application,MFCD00007554 technical grade,usp/ep/jp grade.
Related News: For one, people who are surrounded by others of similar body size may not perceive their weight to be outside of the norm and therefore not seek out bariatric surgery,” said Sandon. “[And] there are differences in ethnicities and culture between states with the highest rates of obesity compared to states with lower rates. Phenyl-vinylsulfon manufacturer In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. Phenyl-vinylsulfon supplier The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Phenyl-vinylsulfon vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Phenyl-vinylsulfon factory In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Phenyl-vinylsulfon vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Phenyl-vinylsulfon factory In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.
